Awards are named in honor of two highly respected and successful lupus investigators and are part of the Lupus Foundation of America’s national lupus research program.
Sandra C. Raymond, President & CEO of the Lupus Foundation of America, issued the following statement in response to Eli Lilly and Company’s announcement of the results of two Phase III clinical trials of tabalumab.
The Lupus Foundation of America announced four grants that will allow lupus investigators to continue critical lupus research. Another grant will be used to develop a groundbreaking diagnostic tool for children with lupus-related kidney inflammation or lupus nephritis.
Results show how disease takes a toll on life for people with lupus and lupus caregivers
Leading Orgs Take to the Hill to Discuss Need to Accelerate New Medicines for Lupus & Other Diseases
Lupus Foundation of America and Rheumatology Research Foundation hold congressional briefing
Lupus Foundation of America announces its 2014 National Lupus Research Program Summer Fellowships and Career Development Awards
Dr. Richardson’s work has provided a strong foundation from which further advances in the understanding and treatment of lupus can be made.